Keyphrases
96-well
33%
96-well Plate
16%
Antibody Inhibition
16%
Antibody Titer
16%
Antibody-mediated
16%
Assay Variation
33%
Capillary Flow
16%
Chondroitin Sulfate
33%
Clinical Development
100%
Comparing Data
16%
Erythrocyte Adhesion
83%
Ex Vivo Placental Perfusion
16%
Functional Assay
100%
High Sensitivity
16%
Id2a
16%
In Vitro Assay
33%
In Vivo Conditions
16%
Infected Erythrocytes
100%
Inhibitory Activity
16%
Liposomal Formulation
16%
Malaria in Pregnancy
16%
Malaria Vaccine
100%
Perfusion
50%
Petri Dish
16%
Petri-dish Assay
66%
Phase I Trial
16%
Placenta
16%
Placental Malaria
100%
Placental Tissue
16%
Plasmodium Falciparum
16%
Pregnant Women
16%
Serial Dilution
16%
VAR2CSA
50%
Biochemistry, Genetics and Molecular Biology
Avidity
100%
Capillary Flow
33%
Chondroitin Sulfate
66%
Dilution
33%
Erythrocyte Adhesiveness
33%
ID1
33%
Offspring
33%
Perfusion
100%
Phase I Trials
33%
Placenta Perfusion
33%
Plasmodium falciparum
33%
Titer
33%
Pharmacology, Toxicology and Pharmaceutical Science
Chondroitin Sulfate
66%
Malaria Vaccine
100%
Phase I Trials
33%
Placenta Malaria
100%
Plasmodium falciparum
33%
Immunology and Microbiology
Antibody Titer
20%
Capillary Flow
20%
Dilution
20%
Erythrocyte
100%
Erythrocyte Adhesiveness
20%
Offspring
20%
Perfusion
60%
Placenta
20%
Placenta Perfusion
20%
Plasmodium falciparum
20%